Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caviar Biotec is a UK-based private biotechnology company developing caviar-derived biologic ingredients and formulations for health, cosmetic, and nutrition applications. The company specializes in patented extraction, recovery, biosynthesis, and culture technologies that generate animal-derived, biomimetic, and cell-cultured caviar ingredients. Its commercial focus appears to be formulation-ready caviar oils, protein extracts, and related bioactive fractions for cosmeceutical and nutraceutical use rather than prescription therapeutics. The business positions itself at the intersection of marine biotechnology, premium bioactives, and sustainable ingredient development. Although it uses biotechnology language and health-oriented claims, it does not appear to have a traditional drug-development pipeline with named clinical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caviar.